ArticleMolecular therapy. Methods & clinical development2019

Gene Therapy for Parkinson's Disease: Preclinical Evaluation of Optimally Configured TH:CH1 Fusion for Maximal Dopamine Synthesis.

Romina Aron Badin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.